Mercer Global Advisors »

Akebia Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $24k 20k 1.22
2023-09-30 $23k 20k 1.15
2023-06-30 $18k 20k 0.90

More positions owned by Mercer Global Advisors

Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Apple (AAPL)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Vanguard Tax-managed Intl Ftse Dev M (VEA)
Vanguard Charlotte Fds Intl Bd Idx Etf (BNDX)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Min Vol (USMV)
Dimensional Etf Trust Us High Profitab (DUHP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Shrt Nat Mun Etf (SUB)
Ishares Tr Msci Intl Moment (IMTM)

View all positions for Mercer Global Advisors

Top funds holding Akebia Therapeutics

Satter Management
Vanguard Group
Susquehanna International
Millennium Management
Jacobs Levy Equity Management
Federated Investors
Assenagon Asset Management
Connor, Clark & Lunn Investment Management
Citadel Advisors
Citigroup
Bank of America Corporation
Sapient Capital
Two Sigma Investments
Russell Investments
Two Sigma Advisers

View all funds holding Akebia Therapeutics